Teladoc Inc (TDOC) Position Lowered by Deutsche Bank AG

Deutsche Bank AG lessened its position in shares of Teladoc Inc (NYSE:TDOC) by 18.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 192,471 shares of the health services provider’s stock after selling 44,107 shares during the quarter. Deutsche Bank AG owned about 0.34% of Teladoc worth $6,706,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of TDOC. SG Americas Securities LLC bought a new position in shares of Teladoc during the 4th quarter worth approximately $101,000. Montag A & Associates Inc. bought a new position in shares of Teladoc during the 4th quarter worth approximately $200,000. Buckley Wealth Management LLC bought a new position in shares of Teladoc during the 4th quarter worth approximately $221,000. Brown Advisory Inc. increased its stake in Teladoc by 38.3% during the 3rd quarter. Brown Advisory Inc. now owns 10,521 shares of the health services provider’s stock valued at $348,000 after purchasing an additional 2,915 shares in the last quarter. Finally, California Public Employees Retirement System increased its stake in Teladoc by 52.1% during the 3rd quarter. California Public Employees Retirement System now owns 11,409 shares of the health services provider’s stock valued at $378,000 after purchasing an additional 3,909 shares in the last quarter.

How to Become a New Pot Stock Millionaire

In other news, CFO Mark Hirschhorn sold 100,000 shares of the company’s stock in a transaction on Wednesday, February 28th. The shares were sold at an average price of $39.60, for a total value of $3,960,000.00. Following the sale, the chief financial officer now directly owns 98,960 shares of the company’s stock, valued at approximately $3,918,816. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Adam C. Vandervoort sold 47,123 shares of the company’s stock in a transaction on Monday, March 5th. The shares were sold at an average price of $39.36, for a total transaction of $1,854,761.28. Following the completion of the sale, the insider now directly owns 19,338 shares in the company, valued at $761,143.68. The disclosure for this sale can be found here. Insiders sold a total of 364,494 shares of company stock worth $14,665,947 over the last ninety days. Insiders own 4.47% of the company’s stock.

A number of research analysts have issued reports on the stock. Wells Fargo set a $46.00 price target on shares of Teladoc and gave the company a “buy” rating in a research note on Friday. ValuEngine upgraded shares of Teladoc from a “hold” rating to a “buy” rating in a research note on Monday, April 2nd. KeyCorp restated an “overweight” rating and set a $50.00 price target (up previously from $41.00) on shares of Teladoc in a research note on Thursday, March 15th. Deutsche Bank lowered shares of Teladoc from a “buy” rating to a “hold” rating and set a $45.00 price target on the stock. in a research note on Thursday, March 15th. Finally, Canaccord Genuity upped their price target on shares of Teladoc from $43.00 to $45.00 and gave the company a “buy” rating in a research note on Wednesday, February 28th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and thirteen have given a buy rating to the stock. Teladoc presently has a consensus rating of “Buy” and an average price target of $41.67.

TDOC stock opened at $39.15 on Monday. The firm has a market capitalization of $2,416.57, a PE ratio of -23.73 and a beta of 0.36. The company has a current ratio of 3.87, a quick ratio of 3.87 and a debt-to-equity ratio of 0.37. Teladoc Inc has a 12 month low of $22.73 and a 12 month high of $44.65.

Teladoc (NYSE:TDOC) last released its quarterly earnings data on Tuesday, February 27th. The health services provider reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.40) by ($0.10). The business had revenue of $77.14 million during the quarter, compared to analysts’ expectations of $76.14 million. Teladoc had a negative net margin of 45.77% and a negative return on equity of 20.95%. research analysts expect that Teladoc Inc will post -1.37 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece was first posted by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3342602/teladoc-inc-tdoc-position-lowered-by-deutsche-bank-ag.html.

Teladoc Company Profile

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Inc (NYSE:TDOC).

Institutional Ownership by Quarter for Teladoc (NYSE:TDOC)

Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Analysts Set Seagate Technology  Price Target at $53.51
Analysts Set Seagate Technology Price Target at $53.51
Conatus Pharmaceuticals  Receives $12.00 Average Price Target from Analysts
Conatus Pharmaceuticals Receives $12.00 Average Price Target from Analysts
21Vianet Group  Receives Daily Media Impact Rating of 0.16
21Vianet Group Receives Daily Media Impact Rating of 0.16
Frontier Communications  Receives Coverage Optimism Score of 0.24
Frontier Communications Receives Coverage Optimism Score of 0.24
QAD  Receives News Sentiment Rating of 0.05
QAD Receives News Sentiment Rating of 0.05
Head-To-Head Contrast: Magellan Health  & Mednax
Head-To-Head Contrast: Magellan Health & Mednax


Leave a Reply

© 2006-2018 Ticker Report. Google+.